Back to Blogs
Blog Img

Real World Evidence and its impact on clinical, regulatory and market access

HPG is proud to be supporting ARCS as the Major Sponsor of the upcoming Summit. The theme of Stream B is “Real World Evidence and its impact on clinical, regulatory and market access”. There will be discussions on key topics including:

The Australian real world evidence and data landscape, the impact of COVID and the future of RWE in Australia.

How RWE is playing a transformational role in clinical development and healthcare delivery, driven by the increasing supply of and demand for real world data.

How effective cross-functional evidence planning can assist with translating real world data to real world patient benefits.

How RWE can support and enhance regulatory submissions.

The role that RWE plays in the evidence package supporting new product reimbursement and launch success.

How innovative methodologies can be used to overcome RWE challenges.

Register at: https://www.arcs.com.au/events/event/LSCRWE121020 to hear from a range of industry leaders including:

Brittany Schoeninger,Jan Lewis,George Papadopoulos,Nancy A. Dreyer, Tam Nguyen, Monique Stone,Claire Behm,Andrew Wilson,Katrina Lapham,Greg O'Toole,Mike Da Gama,Michael Winlo

HPG (Healthcare Professionals Group)
Sydney (02) 8877 8777
Melbourne (03) 99387100